The Department of Veterans Affairs, New York & New Jersey Health Care Network - South (VISN 2 South) intends to award a short term bridge sole-source, firm fixed price FSS-BPA (Blanket Purchase Agreement) to Tosoh Bioscience, Inc., 6000 Shoreline Court, South San Francisco, CA 94080 in accordance with FAR Subpart 8.405-6. The FSS-BPA will be effective April 1, 2018 through September 30, 2018. The acquisition sought is a Bridge BPA that will cover 6 months of reagents, consumables, supplies needed to produce a cost-per-reportable result (CPRR) and for the continued usage of contractor-owned equipment currently on-site at VISN 2 South Medical Centers. VA personnel utilize the equipment and reagents to perform patient Hemoglobin A1c testing. The NAICS is 334516 with a small business size standard of 1,000 employees. The current FSS-BPA with Tosoh will expire on March 31, 2018 and this Bridge BPA is needed to continue to provide HbA1c testing until a new long-term BPA is awarded later this year. This notice of intent is not a request for competitive proposals and no solicitation will be made available. Any responses received no later than COB January 26, 2018 will be considered for the purposes of determining the market place for future procurements. The Government will not pay for information submitted. Any information submitted in response to this notice of intent is strictly voluntary. This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement.

Bid Protests Not Available